Page last updated: 2024-08-23

idarubicin and Liver Cirrhosis

idarubicin has been researched along with Liver Cirrhosis in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Adam, H; Aho, LS; Bedenne, L; Boulin, M; Cercueil, JP; Di Martino, C; Fagnoni, P; Guiu, B; Hillon, P; Jouve, JL; Lepage, C; Minello, A1

Other Studies

1 other study(ies) available for idarubicin and Liver Cirrhosis

ArticleYear
Predictive factors of transarterial chemoembolisation toxicity in unresectable hepatocellular carcinoma.
    Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver, 2014, Volume: 46, Issue:4

    Topics: Acute Kidney Injury; Adult; Aged; Aged, 80 and over; Aspartate Aminotransferases; Carcinoma, Hepatocellular; Chemical and Drug Induced Liver Injury; Chemoembolization, Therapeutic; Cohort Studies; Doxorubicin; Female; Hepatic Encephalopathy; Hepatitis B, Chronic; Hepatitis C, Chronic; Humans; Idarubicin; Liver Cirrhosis; Liver Cirrhosis, Alcoholic; Liver Failure, Acute; Liver Neoplasms; Logistic Models; Male; Middle Aged; Multivariate Analysis; Retrospective Studies; Risk Factors; Treatment Outcome; Tumor Burden

2014